Skin of Color
Neal Bhatia, MD, FAAD
Instead of just restarting our practices after COVID-19, why don’t we hit reset? Here’s how.
Mark D. Kaufmann, MD, FAAD
A look at seven factors affecting the market.
David B. Mandell, JD, MBA, and Robert Peelman, CFP
Early studies offer some hope for emerging therapies for repigmentation.
Seemal Desai, MD
From investigational JAK inhibitors to eyebrow transplants, here’s a look at the latest in hair restoration.
Francisco Jimenez, MD, FISHRS
Although biologic medications have proven to be highly effective in the treatment of psoriasis, there remains a need for oral medications that offer similar success rates. Here’s a look in the pipeline.
Donovan G. Kearns, BS; Shelley K. Uppal, BS; Vipawee S. Chat, BS; and Jashin J. Wu, MD, FAAD
A growing body evidence suggests CBD may help with common symptoms of dermatologic diseases. Here’s what we know so far.
Jennifer Cather, MD
Here’s a closer look at the novel topical being studied for psoriasis and atopic dermatitis.
Brett King, MD, PhD
There is concern about the immunosuppressive or immunomodulatory effects of oral and biologic medications in patients with skin disease.
Shelley K. Uppal, BS; Donovan G. Kearns, BS; Vipawee S. Chat, BS; and Jashin J. Wu, MD, FAAD
The new CO2 laser lash lift results in naturally curled lashes and creates the appearance of bigger, brighter eyes.
Julie Woodward, MD
Exploring irritable bowel syndrome’s link to dermatologic conditions.
Marta Turowski, and Peter Lio, MD
DeAnna Diaz, MS, MBS, OMS-III; Sarah Li, OMS-III; Hanaa Khadraoui, OMS-III; Sonu Sahni, MD; and Chérie M. Ditre, MD
Stay up to date on all things Dermatology by signing up to recieve our print publication or subscribe to our email alerts.
July 2020 Insert